Actos

Rediff.com » News » Actos

News for Actos

News
Business

Govt may ban diabetes drugs if found harmful

In the wake of a US study linking two main diabetes drugs to heart attacks, the Indian government has warned of banning these medicines if found harmful. Taking the study seriously, the government......

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune. Wyeth and its new......

Patents: Nestle,Takeda sue Lupin, Torrent

Galderma Laboratories, a joint venture dermatology company between Nestle and L'Oreal, and the New York University have sued Lupin Ltd for infringing the patent rights of one of its main drugs,......

US crisis may hit Indian drug R&D

Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal......

Off-patents provide big opportunity: Dr Reddy

One of the two molecules developed by Dr Reddy's was named after its chairman Dr K Anji Reddy and another after Lord Balaji. Reddy, who started new drug research in the country a decade and a half......

Rediff News

Actos

News for Actos

Govt may ban diabetes drugs if found harmful

Ranbaxy may get approval for multi-billion dollar drug

Pfizer, Wyeth sue Ranbaxy over drug

Patents: Nestle,Takeda sue Lupin, Torrent

US crisis may hit Indian drug R&D

Off-patents provide big opportunity: Dr Reddy

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS